Abstract
World Health Organization (WHO) estimates that cardiovascular disease (CVD) and human immunodeficiency virus (HIV) will top the causes for global mortality and disability in 2030. How to develop and implement effective primary prevention strategy in HIV-infected patients with high cardiovascular
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.